-
effectivehealthcare.ahrq.gov/products/meditation/research
-
effectivehealthcare.ahrq.gov/sites/default/files/thompson_eccs2012.pdf
January 01, 2012 - Presenting risk information increased perceived risk without
increasing
worry,
fear,
or anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - reports have observed severe adverse events,
including delayed-onset suicidal ideation, dysphoria, and anxiety … Depress
Anxiety. 2014 Apr;31(4):335-43. Also available:
http://dx.doi.org/10.1002/da.22253. … Depress Anxiety. 2014
Apr;31(4):297-307. Also available:
http://dx.doi.org/10.1002/da.22224. … Two
cases of delayed-onset suicidal ideation,
dysphoria and anxiety after ketamine infusion in
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-children_research-protocol.pdf
December 11, 2015 - suicide.2
The evidence base for pediatric mental health interventions that target mood disorders,
anxiety … Fields] OR psychopathology OR "Adjustment Disorders"[Mesh] OR
"adjustment disorder"[All Fields] OR "anxiety … posttraumatic stress disorder"[All Fields] OR "post-traumatic stress
disorder"[All Fields] OR "generalized anxiety … ] OR "obsessive compulsive disorder"[All Fields] OR "reactive attachment
disorder"[All Fields] OR "Anxiety … , Separation"[Mesh] OR "separation anxiety disorder"[All Fields] OR
"Eating Disorders"[Mesh] OR "eating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - domains in the postmenopause for quality-of-life outcomes: depression, somatic,
memory, vasomotor, anxiety … ●
MQOL ● ● ● ●
Women’s Health Questionnaire ● ● ● ● ●
Beck Depression Inventory ●
Beck Anxiety … Inventory ●
Hamilton Depression Rating Scale ●
Hamilton Anxiety Rating Scale ●
McCoy … Symptoms
“behavioral symptoms” (mh) OR “mood disorders” (mh) OR irritability OR depression OR
despair OR anxiety … disorder’/exp OR ‘mood disorders’/exp OR
‘irritability’/exp OR ‘depression’/exp OR ‘despair’/exp OR ‘anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - rationale is given on this page or
referenced elsewhere as to why only PTSD was chosen as the SMI
anxiety … An explanation should have been provided
somewhere in the document if this was the only anxiety disorder … PTSD was not chosen as the only anxiety disorder to
represent SMI.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
August 10, 2016 - Survey-36, Skindex, Skin Cancer Index, Skin Cancer Quality of Life
Impact Tool)
• Mental health, anxiety … State-Trait Anxiety Inventory, Hospital Anxiety and
Depression Scale, Impact of Event Scale)
• Patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
December 20, 2011 - Difficulty falling or staying asleep
• Irritability or outburst of anger
• Difficulty concentrating
• Hypervigilance … Exposure-based therapy involves confrontation with frightening stimuli and is continued
until anxiety … such as education, muscle relaxation training, breathing
retraining, role playing, etc., to manage anxiety … include prevention/reduction of comorbid
medical or psychiatric conditions (e.g., depressive symptoms, anxiety … of comorbid medical or psychiatric conditions (e.g.,
coronary artery disease, depressive symptoms, anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disposition-comments.pdf
April 10, 2025 - The citation and prevalence numbers for children
with current behavior problems, anxiety and
depression … Assess attention- easy to use VV
scales fro ADHD, x 3 types, Conduct , ODD and
anxiety - every quarterly … Conclusion The approach has to be integrative than
depending on parent subjectively judged VV
scales, Anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
May 01, 2009 - For
example, duloxetine was approved for use in generalized anxiety (2/27/07) and atorvastatin for … Most Common
Off-label Indication
1 quetiapine Schizophrenia Bipolar, maintenance a,c Depression Anxiety … Enthesopathy
10 lisinopril Hypertension Coronary artery disease Diabetes
11 duloxetine Depression Anxiety … Bipolar b
12 trazodone Depression Sleep disturbance Anxiety Bipolar b
13 olanzapine Schizophrenia … Depression Dementia Anxiety
14 epoetin alfa Chron renal failure Anemia of chronic disease Myelodysplastic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-protocol.pdf
June 01, 2023 - individual’s bereavement process may at best be ineffective, and at worst, create undue
distress and anxiety … Depress Anxiety. 2011 Feb;28(2):103-17. doi: 10.1002/da.20780. PMID:
21284063.
3. … Complicated grief as a disorder distinct
from bereavement-related depression and anxiety: a replication … The influence of symptoms of prolonged grief disorder,
depression, and anxiety on quality of life among
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - , measures of depression and generalized anxiety, quality of life, and treatment satisfaction but did … Scale Assessment Time (Weeks) for Anxiety Variance Type for Anxiety Intervention A, Baseline N Intervention … NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Anxiety … NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Dry mouth, headache, anxiety … and Depressions Scale - Anxiety
HADS-D Hospital Anxiety and Depressions Scale - Depression
HIV human
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
March 07, 2021 - As such, we will identify literature reporting on caregiver
issues such as anxiety. … • Cognitive function
• Functional performance (including school)
• Social function
• Caregiver anxiety … function
• Cognitive function
• Functional performance
(including school)
• Social function
• Caregiver anxiety
-
effectivehealthcare.ahrq.gov/products/behavioral-health-screening/protocol
-
effectivehealthcare.ahrq.gov/products/behavioral-health-screening/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
August 06, 2014 - interaction-based
interventions, joint attention interventions, and cognitive
behavior therapy (CBT) for anxiety … sleep
problems, elopement (wandering), pica (ingesting inedible
items), behaviors associated with anxiety … The first sentence says that “five of six
RTCs identified in the literature measured anxiety
symptoms … The fact that we now that the anxiety studies
included 5 RTCs is useful information and this type of … outcomes targeted
(e..g, p. 33 ...interventions targeting symptoms commonly
associated with ASD such as anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
June 01, 2022 - Harms Interactive online tool Noninteractive online tool 1 RCT (231) No difference in patient reported anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - Compared with placebo, study participants treated with acamprosate were more
likely to experience anxiety … events, including paresthesias, taste
abnormalities, anorexia, difficulty with concentration/attention, nervousness
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-disposition-comments.pdf
June 28, 2022 - , there was insufficient evidence for
several of the stated outcomes of interest, such as maternal anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - found no
differences in pain improvement
and pain response between the
two formulations; sleep, anxiety … pregabalin associated with
improved pain, pain response,
and sleep interference but no
improvement in anxiety … between pregabalin formulations on DPRS 30 and 50 percent
pain reduction, sleep, and depression or anxiety … interference (p<0.001).9 There was also no
difference between pregabalin versus placebo on the Hospital Anxiety … and Depression Scale
(HADS) anxiety scale, but pregabalin was associated with improved HADS depression